Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biodelivery Sci Intl (BDSI) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 105,530
  • Shares Outstanding, K 53,640
  • Annual Sales, $ 48,230 K
  • Annual Income, $ -37,670 K
  • 36-Month Beta 1.96
  • Price/Sales 2.41
  • Price/Book 0.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.65 +21.21%
on 01/03/17
2.20 -9.09%
on 12/15/16
+0.05 (+2.56%)
since 12/13/16
3-Month
1.50 +33.33%
on 11/23/16
2.53 -20.95%
on 10/25/16
-0.36 (-15.25%)
since 10/13/16
52-Week
1.50 +33.33%
on 11/23/16
4.39 -54.44%
on 03/08/16
-1.59 (-44.29%)
since 01/13/16

Most Recent Stories

More News
Is the Options Market Predicting a Spike in BioDelivery (BDSI) Stock?

Options traders are pricing in a big move for BioDelivery (BDSI) shares as its huge implied volatility could mean there's a trade developing.

Endo International (ENDP): Can the Stock Rebound in 2017?

Can Endo make a comeback in 2017 seeing that the company is presently in the middle of the drug pricing controversy?

BioDelivery Sciences Announces the Hiring of Peter Ginsberg as Vice President of Business Development

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Peter Ginsberg has joined the company as Vice President of Business Development. Mr. Ginsberg joins BDSI with over 25 years of business...

BioDelivery Sciences Announces Clonidine Topical Gel for Painful Diabetic Neuropathy Phase 2b Trial Fails to Meet its Primary Efficacy Endpoint

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that its Phase 2b clinical study assessing the efficacy and safety of Clonidine Topical Gel for the management of painful diabetic neuropathy...

Endo (ENDP) Inks Deal to Return Belbuca Rights to BioDelivery

Endo (ENDP) announced that it has entered into an agreement to return the rights for Belbuca to BioDelivery (BDSI).

Endo Announces Strategic Updates for BELBUCA(TM) and U.S. Branded Pain Portfolio

Endo Returns Rights for BELBUCA(TM) to BDSI and Eliminates Pain Sales Field Force, Directing Greater Focus and Resources on the Specialty Branded Business

Endo Announces Strategic Updates for BELBUCA(TM) and U.S. Branded Pain Portfolio

Endo International plc (NASDAQ / TSX: ENDP) announced today that it has entered into an agreement with its partner, BioDelivery Sciences International, Inc. (BDSI), to return the BELBUCA(TM) (buprenorphine)...

Endo Announces Strategic Updates for BELBUCA(TM) and U.S. Branded Pain Portfolio

Endo International plc (NASDAQ / TSX: ENDP) announced today that it has entered into an agreement with its partner, BioDelivery Sciences International, Inc. (BDSI), to return the BELBUCATM (buprenorphine)...

BioDelivery Sciences: Can Bunvail and Belbuca's Sales Improve?

On Nov 25, 2016, we issued an updated research report on BioDelivery Sciences International, Inc. (BDSI).

Company News for November 10, 2016

Companies in the News are: BDSI,DISH,EGRX,HCAP

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Strengthening.

See More

Business Summary

BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any...

See More

Support & Resistance

2nd Resistance Point 2.07
1st Resistance Point 2.03
Last Price 2.00
1st Support Level 1.93
2nd Support Level 1.87

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.